Email Alerts

Want to stay up to date on our news, events, and filings?

Set up your email alerts. Learn More

Press Releases

All Releases
View Summary Insmed to Present at the JMP Securities Healthcare Conference
Jun 20, 2014
PDF 11.8 KB Add to Briefcase
View Summary Insmed Appoints David R. Brennan to Its Board of Directors
May 29, 2014
PDF 12.5 KB Add to Briefcase
View Summary Insmed Announces Positive Open Label Data from Phase 2 Clinical Trial of ARIKAYCE for Treatment Resistant Nontuberculous Mycobacterial Lung Infections
May 20, 2014
PDF 18.2 KB Add to Briefcase
View Summary Insmed Announces Data Presentations for ARIKAYCE in Two Orphan Lung Diseases at the American Thoracic Society Meeting
May 13, 2014
PDF 13.1 KB Add to Briefcase
View Summary Insmed to Participate in the Bank of America Merrill Lynch 2014 Health Care Conference
May 12, 2014
PDF 11.7 KB Add to Briefcase
View Summary Insmed Reports First Quarter 2014 Financial Results
May 8, 2014
PDF 19.3 KB Add to Briefcase
View Summary Insmed to Participate in the 13th Annual Needham & Co. Healthcare Conference
Apr 7, 2014
PDF 11.8 KB Add to Briefcase
View Summary Insmed Announces Leadership Team Transitions and Appointments to Expand Support for Growth Opportunities
Apr 2, 2014
PDF 15.5 KB Add to Briefcase
View Summary Insmed Announces Results from Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacterial Lung Infections
Mar 26, 2014
PDF 29.8 KB Add to Briefcase
View Summary Insmed to Announce Results From U.S. Phase 2 Clinical Trial for Treatment Resistant Nontuberculous Mycobacteria Lung Infections
Mar 25, 2014
PDF 12.2 KB Add to Briefcase
View Summary Insmed Reports 2013 Fourth Quarter and Full Year Financial Results
Mar 6, 2014
PDF 23.3 KB Add to Briefcase
  Insmed Provides Interim Update from Two-Year, Open-Label Extension Study of ARIKACE to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients
Feb 19, 2014
PDF 321.8 KB Add to Briefcase
View Summary ARIKACE to Receive Orphan Medicinal Product Designation in the European Union to Treat Lung Infections Caused by Nontuberculous Mycobacteria
Feb 10, 2014
PDF 13.0 KB Add to Briefcase
View Summary Insmed to Present at the Leerink Swann Global Healthcare Conference
Feb 4, 2014
PDF 11.9 KB Add to Briefcase
View Summary Insmed Reports Third Quarter 2013 Financial Results
Nov 5, 2013
PDF 23.2 KB Add to Briefcase
View Summary Insmed Appoints David W.J. McGirr to Its Board of Directors
Nov 1, 2013
PDF 13.6 KB Add to Briefcase
View Summary Insmed to Host Third Quarter 2013 Financial Results Conference Call on Tuesday, November 5, 2013
Oct 23, 2013
PDF 12.5 KB Add to Briefcase
View Summary Insmed Completes Enrollment of Phase 2 Clinical Trial of ARIKACE to Treat Nontuberculous Mycobacteria Lung Disease in U.S. and Canada
Oct 15, 2013
PDF 17.9 KB Add to Briefcase
View Summary Insmed to Present at Leerink Swann Rare Disease Roundtable
Sep 25, 2013
PDF 11.0 KB Add to Briefcase
View Summary Insmed Fortifies Global Patent Portfolio
Sep 11, 2013
PDF 13.3 KB Add to Briefcase
Showing 1-20 of 378 Page: 1 2 3 4 5 ... 19  Next 20
Add to Briefcase = add release to Briefcase

Prior Announcements

Key Clinical Publications

Insmed actively publishes and presents clinical data for ARIKAYCE.

Learn More

Email Alerts

Want to stay up to date on our news, events, and filings?

Set up your email alerts. Learn More

Investor & Media Contacts

Investor Relations
Anne Marie Fields
Senior Vice President
LHA
Phone: (212) 838-3777
E-mail

Bruce Voss
Managing Director
LHA
Phone: (310) 691-7100
E-mail

loading